Tag Archives: healthcare

On March 14, we published this piece looking at Endonovo Therapeutics Inc (OTCMKTS:ENDV). Our thesis was relatively simple – that the company was approaching a couple of key catalysts that looked set to inject some long awaited upside momentum...

Just last week we took a look at Cellceutix Corp (OTCMKTS:CTIX) as part of this piece. Our thesis on the stock was simple: forget the negative attention surrounding the company, and focus on the science. Well, we just got some fresh news related...

OXIS International, Inc. (OTCMKTS:OXIS) just announced that it has entered into a sponsored research agreement with the University of Minnesota, designed to help forward the development of one of its preclinical assets. This is a company we’ve...

Full-year 2016 financials are hitting press thick and fast in the biotech space right now, and injecting plenty of volatility into the sector. One company that just put out its numbers, but is really moving for a variety of other reasons, is...

Cerulean Pharma Inc (NASDAQ:CERU) is running up towards the end of the week on suggestions that the company could be fielding buy out offers, or at least pitching for the sale of some of its lead development assets. The company closed out on...

Here at Insider Financial, we work hard to uncover potential movers ahead of the wider markets. In the biotech space, there are plenty of these sorts of opportunities, but there’s so much noise in the sector that separating the wheat...

Neovasc Inc (US) (NASDAQ:NVCN) ran up this week as management announced that it will be putting out fourth quarter and fiscal  2016 numbers on March 23 (next Tuesday) and that – alongside the numbers – we will get a conference call to...

Having slowly devalued throughout the latter half of 2016 and into the first quarter of this year, Endonovo Therapeutics Inc (OTCMKTS:ENDV) is staging something of a recovery. The company went for $0.012 at the beginning of March, down nearly...

Catabasis Pharmaceuticals Inc (NASDAQ:CATB) ran up close to 50% at the end of the last week, without any real fundamental catalysts seemingly driving the action. The company is set to stage a conference call this coming Thursday (March 16)...

Kura Oncology Inc (NASDAQ:KURA) is a big biotech runner this week, with the company gaining more than 30% during the Tuesday session, and looking set to pick up further strength on Wednesday on the back of a few percentage point run premarket....

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter